Soc. Generale Call 120 AZN 20.12..../ DE000SU796Y8 /
2024-08-01 8:13:50 AM | Chg.+0.01 | Bid11:37:13 AM | Ask11:37:13 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.19EUR | +0.85% | 1.16 Bid Size: 15,000 |
1.17 Ask Size: 15,000 |
Astrazeneca PLC ORD ... | 120.00 GBP | 2024-12-20 | Call |
GlobeNewswire
06-26
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire
06-18
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
06-18
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
06-13
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...